{
    "clinical_study": {
        "@rank": "159797", 
        "arm_group": {
            "arm_group_label": "Adult Growth Hormone deficient Patients", 
            "description": "Patients with GHD on Genotropin\u00ae replacement therapy."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the long term treatment outcomes of Growth Hormone\n      treatment in patients who are prescribed and treated with Genotropin. Also, plan to\n      determine the relationships between clinical status, dosage schedule and response to\n      Genotropin treatment.\n\n      This study will also contribute to our knowledge of adult Growth Hormone Deficiency,\n      including transition period in Childhood Onset Growth Hormone Deficiency and its treatment."
        }, 
        "brief_title": "A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients", 
        "completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Growth Hormone Deficiency", 
        "condition_browse": {
            "mesh_term": [
                "Dwarfism, Pituitary", 
                "Endocrine System Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients within inclusion criteria are asked to participate in the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients of 18 years of age and above and fulfilling one of the three\n             alternatives a-c below;\n\n               1. Newly diagnosed with GHD according to the current medical standard.\n\n               2. Diagnosed with GHD before 2013 and previously treated with Genotropin and\n                  followed in KIMS\u00ae.\n\n               3. Transition patients diagnosed with CO-GHD before 2013.\n\n          -  Prescribed Genotropin at the time of inclusion.\n\n          -  Evidence of a personally signed and dated informed consent document indicating that\n             the patient (or a legally acceptable representative) has been informed of all\n             pertinent aspects of the study.\n\n        Exclusion Criteria:\n\n          -  Patients who participate in any concurrent clinical interventional trial where a\n             non-authorized or authorized study medication is used, during their participation in\n             Swedish KIMS\u00ae Xtended. Concurrent studies which do not include any study\n             interventional items (whether medications or devices) are allowed."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients wiht Growth Hormone Deficiency"
            }
        }, 
        "enrollment": {
            "#text": "900", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01947894", 
            "org_study_id": "A6281313"
        }, 
        "intervention": {
            "arm_group_label": "Adult Growth Hormone deficient Patients", 
            "description": "Non Interventional Study", 
            "intervention_name": "Non Interventional Study", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 14, 2014", 
        "link": {
            "description": "To obtain contact information for a study center near you, click here.", 
            "url": "https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6281313&StudyName=A%20Prospective%20Non-Interventional%20Study%20Protocol%20With%20Primary%20Data%20Collection%20-%20%20Assessment%20Of%20The%20Long%20Term%20Treatment%20Outcomes%20Of%20Genotr"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Goteborg", 
                        "country": "Sweden", 
                        "zip": "413 45"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "171 76"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Uppsala", 
                        "country": "Sweden", 
                        "zip": "751 85"
                    }, 
                    "name": "Pfizer Investigational Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients", 
        "overall_contact": {
            "last_name": "Pfizer CT.gov Call Center", 
            "phone": "1-800-718-1021"
        }, 
        "overall_official": {
            "affiliation": "Pfizer", 
            "last_name": "Pfizer CT.gov Call Center", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "This Non-Interventional study does not include pre-specified endpoints, but collects information from adult subjects recieving Genotropin treatment in a real world clinic setting.", 
            "safety_issue": "No", 
            "time_frame": "no time frame"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01947894"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pfizer", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pfizer", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}